Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

74 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Development and validation of the NEOS2 score for prediction of long-term outcomes and improvement after first-line immunotherapy in patients with anti-NMDAR encephalitis: an international cohort study.
Brenner J, Bastiaansen AEM, Guasp M, Muñiz-Castrillo S, Iizuka T, de Bruijn MAAM, Muñoz-Lopetegi A, Martínez-Hernández E, Picard G, Vogrig A, Millot M, Finke C, Geis C, Lewerenz J, Melzer N, Prüss H, Räuber S, Ringelstein M, Rostàsy K, Sühs KW, Thaler FS, Wandinger KP, Wurdack K, Crijnen YS, Kerstens J, van Steenhoven RW, Veenbergen S, Schreurs MWJ, van den Berg R, Volovici V, Neuteboom RF, de Vries JM, Sillevis Smitt PAE, Nagtzaam MMP, Franken SC; GENERATE Study Group; Dalmau J, Leypoldt F, Honnorat J, Titulaer MJ. Brenner J, et al. Among authors: muniz castrillo s. Lancet Reg Health Eur. 2025 Dec 11;62:101562. doi: 10.1016/j.lanepe.2025.101562. eCollection 2026 Mar. Lancet Reg Health Eur. 2025. PMID: 41488792 Free PMC article.
Clinical specificities and outcome of LGI1-antibody encephalitis according to age, sex and HLA.
Campetella L, Villagrán-García M, Farina A, Villard M, Benaiteau M, Vogrig A, Iorio R, Ciano-Petersen NL, Psimaras D, Navarro V, Sempere VP, Gonçalves D, Picard G, Rogemond V, Joubert B, Mignot E, Honnorat J, Muñiz-Castrillo S. Campetella L, et al. Among authors: muniz castrillo s. J Neurol Neurosurg Psychiatry. 2025 Dec 12;97(1):71-80. doi: 10.1136/jnnp-2025-335960. J Neurol Neurosurg Psychiatry. 2025. PMID: 41093636
Risk of Epilepsy and Factors Associated With Time to Seizure Remission in Anti-LGI1 Encephalitis: Long-Term Outcome in 236 Patients.
Baumgartner T, Freyberg M, Campetella L, Crijnen Y, Dargvainiene J, Behning C, Bien CG, Rada A, Prüss H, Rössling R, Kovac S, Strippel C, Thaler FS, Eisenhut K, Lewerenz J, Becker F, Reinecke R, Malter MP, Sühs KW, Tauber SC, Von Podewils F, Melzer N, Wandinger KP, Fernandez Ceballos RA, Kuhle J, Berger K, Bauer T, Rüber T, Racz A, Becker AJ, Pitsch J, Kuhlenbäumer G, Muñiz-Castrillo S, Honnorat J, Titulaer MJ, Leypoldt F, Surges R; and the GENERATE study group. Baumgartner T, et al. Among authors: muniz castrillo s. Neurol Neuroimmunol Neuroinflamm. 2025 Nov;12(6):e200469. doi: 10.1212/NXI.0000000000200469. Epub 2025 Sep 15. Neurol Neuroimmunol Neuroinflamm. 2025. PMID: 40953325 Free PMC article.
Brain atrophy patterns in anti-IgLON5 disease.
Yogeshwar SM, Bartels F, Grüter T, Muñiz-Castrillo S, Picard G, Crijnen YS, Bernard E, Heidbreder A, Zekeridou A, Ringelstein M, Kraft A, Kovac S, Wandinger KP, de Vries JM, Boon AJW, Veenbergen S, Geis C, Penner L, Melzer N, Leypoldt F, Blaabjerg M, Pittock SJ, Gaig C, Sabater L, Santamaria J, Graus F, Dalmau J, Prüss H, Höftberger R, Schreiner B, McKeon A, Lewerenz J, Irani S, Mignot E, Titulaer MJ, Ayzenberg I, Honnorat J, Finke C; IgLON5 Imaging Consortium. Yogeshwar SM, et al. Among authors: muniz castrillo s. Brain. 2026 Mar 5;149(3):884-896. doi: 10.1093/brain/awaf256. Brain. 2026. PMID: 40650880 Free PMC article.
Relapses in Anti-NMDAR Encephalitis: Clinical Characterization and Predictive Features.
Ciano-Petersen NL, Villagrán-García M, Muñiz-Castrillo S, Farina A, Vogrig A, Goncalves D, Nicole F, Rogemond V, Picard G, Aubart M, Psimaras D, Oliver B, Serrano-Castro PJ, Joubert B, Honnorat J. Ciano-Petersen NL, et al. Among authors: muniz castrillo s. Neurol Neuroimmunol Neuroinflamm. 2025 Jul;12(4):e200421. doi: 10.1212/NXI.0000000000200421. Epub 2025 Jun 18. Neurol Neuroimmunol Neuroinflamm. 2025. PMID: 40532146 Free PMC article.
Application of the anti-IgLON5 disease composite score to assess severity, clinical course, and mortality in a French cohort.
Farina A, Villagrán-García M, Abichou-Klich A, Benaiteau M, Bernard E, Campetella L, Cluse F, Desestret V, Dumez P, Fabien N, Goncalves D, Muñiz-Castrillo S, Picard G, Pinto AL, Rogemond V, Vogrig A, Joubert B, Honnorat J. Farina A, et al. Among authors: muniz castrillo s. J Neurol. 2025 Mar 19;272(4):273. doi: 10.1007/s00415-025-13001-7. J Neurol. 2025. PMID: 40106089 Free PMC article.
Novel risk loci in LGI1-antibody encephalitis: genome-wide association study discovery and validation cohorts.
Binks SNM, Elliott KS, Muñiz-Castrillo S, Gilbert E, Kawasaki de Araujo T, Harper AR, Brown AC, Chong AY, Band G, Peris Sempere V, Pinto AL, Costantino F, Rayner NW, Mentzer AJ, Delanty N, Rogemond V, Picard G, Handel AE, Melzer N, Titulaer MJ, Lee ST, Leypoldt F, Kuhlenbaeumer G, Honnorat J, Mignot E, Cavelleri GL, Knight JC, Irani SR. Binks SNM, et al. Among authors: muniz castrillo s. Brain. 2025 Mar 6;148(3):737-745. doi: 10.1093/brain/awae349. Brain. 2025. PMID: 39454566 Free PMC article.
74 results